13F Holdings
中文EN

PHG KONINKLIJKE PHILIPS NV IFRS Annual reports only

X-Ray Apparatus & Tubes & Related Irradiation Apparatus · NYSE · SEC CIK 313216 · Reporting currency EUR · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-1.0%
TTM net income YoY227.5%
TTM EPS YoY224.0%
Revenue 3-yr CAGR0.0%
Net income 3-yr CAGR—

Margins

Gross margin45.2%
Operating margin8.0%
Net margin5.0%
FCF margin—
EBITDA margin14.3%

Returns

ROE7.8%
ROA3.2%
ROIC (approx.)6.5%
Asset turnover0.64x

Leverage & solvency

Liabilities / assets59.2%
Debt / equity0.74x
Current ratio1.32x
Interest coverage4.94x

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio36.9%
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: EUR FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue17.83B18.02B18.17B17.83B17.16B
Cost of revenue9.78B10.25B10.72B10.63B9.99B
Gross profit8.06B7.77B7.45B7.19B7.17B
R&D expense1.70B1.75B1.89B2.09B1.81B
SG&A expense628.00M582.00M608.00M671.00M599.00M
Operating income1.42B529.00M-115.00M-1.53B553.00M
Interest expense288.00M288.00M277.00M235.00M159.00M
Pretax income1.18B123.00M-526.00M-1.73B509.00M
Income tax282.00M963.00M-73.00M-113.00M-103.00M
Net income895.00M-702.00M-466.00M-1.61B3.32B
EBITDA2.55B1.92B1.15B73.00M1.88B
EPS (basic)0.94-0.75-0.49-1.693.52
EPS (diluted)0.93-0.75-0.49-1.693.50
Weighted avg. shares (diluted)962.50M933.37M948.30M951.81M—
Balance sheet
Cash & equivalents2.79B2.40B1.87B1.17B2.30B
Receivables3.53B3.67B3.73B4.12B3.79B
Inventory2.87B3.20B3.49B4.05B3.45B
Current assets9.93B10.02B9.94B10.26B10.35B
PP&E, netmay include right-of-use assets (IFRS)2.22B2.45B2.48B2.64B2.70B
Goodwill9.27B10.38B9.88B10.24B10.64B
Intangibles2.57B2.98B3.19B3.53B3.65B
Total assets26.94B28.98B29.41B30.69B30.96B
Current liabilities7.51B8.15B8.29B7.93B7.45B
Short-term debt1.15B526.00M654.00M931.00M506.00M
Long-term debt6.93B7.11B7.04B7.27B6.47B
Total debt8.09B7.64B7.69B8.20B6.98B
Total liabilities15.95B16.93B17.34B17.41B16.49B
Shareholders' equity10.96B12.01B12.03B13.25B14.44B
Net debt5.29B5.24B5.82B7.03B4.68B
Cash flow statement
Operating cash flow—————
Capital expenditure269.00M317.00M345.00M444.00M397.00M
Depreciation & amortization1.12B1.39B1.26B1.60B1.32B
Stock-based compensation141.00M96.00M88.00M95.00M108.00M
Dividends paid330.00M32.00M70.00M418.00M484.00M
Share buybacks0411.00M662.00M187.00M1.64B

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.